Area assessment of psoriasis lesions for PASI scoring
- PMID: 19557605
- DOI: 10.1080/07434610902744066
Area assessment of psoriasis lesions for PASI scoring
Abstract
Psoriasis is a skin disorder which is caused by a genetic fault. Although there is no cure for psoriasis, there are many treatment modalities to help control the disease. To evaluate treatment efficacy, the current gold standard method, PASI (Psoriasis Area and Severity Index), is used to measure psoriasis severity by evaluating the area, erythema, scaliness and thickness of the plaques. However, the determination of PASI can be tedious and subjective. In this work, we develop a computer vision method that determines one of the PASI parameters, the lesion area. The method isolates healthy and healed skin areas from lesion areas by analysing the hue and chroma information in the CIE L*a*b* colour space. Centroids of healthy skin and psoriasis in the hue-chroma space are determined from selected sample. The Euclidean distance of all pixels from each centroid is calculated. Pixels are assigned to either healthy skin or psorasis lesion classes based on the minimum Euclidean distance. The study involves patients from different ethnic origins having three different skin tones. Results obtained show that the proposed method is able to determine lesion areas with accuracy higher than 90% for 28 out of 30 cases.
Similar articles
-
Objective assessment of psoriasis erythema for PASI scoring.J Med Eng Technol. 2009;33(7):516-24. doi: 10.1080/07434610902744074. J Med Eng Technol. 2009. PMID: 19639508
-
Area assessment of psoriasis lesion for PASI scoring.Annu Int Conf IEEE Eng Med Biol Soc. 2007;2007:3446-9. doi: 10.1109/IEMBS.2007.4353072. Annu Int Conf IEEE Eng Med Biol Soc. 2007. PMID: 18002738
-
Lesion area assessment in psoriasis patients.J Med Eng Technol. 2011 Apr-May;35(3-4):154-60. doi: 10.3109/03091902.2011.554598. Epub 2011 Feb 17. J Med Eng Technol. 2011. PMID: 21323489
-
Scoring and monitoring the severity of psoriasis. What is the preferred method? What is the ideal method? Is PASI passé? facts and controversies.Clin Dermatol. 2010 Jan-Feb;28(1):67-72. doi: 10.1016/j.clindermatol.2009.03.001. Clin Dermatol. 2010. PMID: 20082954 Review.
-
Assessment of disease progress in psoriasis.Arch Dermatol. 1989 Feb;125(2):235-40. Arch Dermatol. 1989. PMID: 2643928 Review.
Cited by
-
A 3D-psoriatic skin model for dermatological testing: The impact of culture conditions.Biochem Biophys Rep. 2016 Sep 30;8:268-276. doi: 10.1016/j.bbrep.2016.09.012. eCollection 2016 Dec. Biochem Biophys Rep. 2016. PMID: 28955966 Free PMC article.
-
Deep Learning Application for Effective Classification of Different Types of Psoriasis.J Healthc Eng. 2022 Jan 15;2022:7541583. doi: 10.1155/2022/7541583. eCollection 2022. J Healthc Eng. 2022. PMID: 35075392 Free PMC article.
-
Portulaca oleracea L. aids calcipotriol in reversing keratinocyte differentiation and skin barrier dysfunction in psoriasis through inhibition of the nuclear factor κB signaling pathway.Exp Ther Med. 2015 Feb;9(2):303-310. doi: 10.3892/etm.2014.2116. Epub 2014 Dec 8. Exp Ther Med. 2015. PMID: 25574190 Free PMC article.
-
Machine Learning Applications in the Evaluation and Management of Psoriasis: A Systematic Review.J Psoriasis Psoriatic Arthritis. 2020 Oct;5(4):147-159. doi: 10.1177/2475530320950267. Epub 2020 Aug 31. J Psoriasis Psoriatic Arthritis. 2020. PMID: 33733038 Free PMC article.
-
Cutaneous lupus erythematosus disease assessment: Highlighting CLE outcome measures.Front Med (Lausanne). 2022 Oct 14;9:968469. doi: 10.3389/fmed.2022.968469. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36314023 Free PMC article. Review. No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical